1 | 1 | | |
---|
2 | 2 | | |
---|
3 | 3 | | EXPLANATION: CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW. |
---|
4 | 4 | | [Brackets] indicate matter deleted from existing law. |
---|
5 | 5 | | *sb0787* |
---|
6 | 6 | | |
---|
7 | 7 | | SENATE BILL 787 |
---|
8 | 8 | | J5 2lr2451 |
---|
9 | 9 | | CF HB 970 |
---|
10 | 10 | | By: Senator Feldman |
---|
11 | 11 | | Introduced and read first time: February 7, 2022 |
---|
12 | 12 | | Assigned to: Finance |
---|
13 | 13 | | |
---|
14 | 14 | | A BILL ENTITLED |
---|
15 | 15 | | |
---|
16 | 16 | | AN ACT concerning 1 |
---|
17 | 17 | | |
---|
18 | 18 | | Managed Care Organizations and Health Insurance Carriers – Prior 2 |
---|
19 | 19 | | Authorization for HIV Postexposure Prophylaxis for Victims of Sexual Offenses 3 |
---|
20 | 20 | | – Prohibition 4 |
---|
21 | 21 | | |
---|
22 | 22 | | FOR the purpose of prohibiting managed care organizations and certain insurers, nonprofit 5 |
---|
23 | 23 | | health service plans, and health maintenance organizations from applying a prior 6 |
---|
24 | 24 | | authorization requirement for prescription drugs used as postexposure prophylaxis 7 |
---|
25 | 25 | | for the prevention of HIV if the drug is prescribed to a victim of an alleged rape or 8 |
---|
26 | 26 | | sexual offense; and generally relating to prescription drugs used as postexposure 9 |
---|
27 | 27 | | prophylaxis for the prevention of HIV infection and prior authorizations. 10 |
---|
28 | 28 | | |
---|
29 | 29 | | BY repealing and reenacting, without amendments, 11 |
---|
30 | 30 | | Article – Health – General 12 |
---|
31 | 31 | | Section 15–103(a)(1) 13 |
---|
32 | 32 | | Annotated Code of Maryland 14 |
---|
33 | 33 | | (2019 Replacement Volume and 2021 Supplement) 15 |
---|
34 | 34 | | |
---|
35 | 35 | | BY adding to 16 |
---|
36 | 36 | | Article – Health – General 17 |
---|
37 | 37 | | Section 15–103(b)(31) 18 |
---|
38 | 38 | | Annotated Code of Maryland 19 |
---|
39 | 39 | | (2019 Replacement Volume and 2021 Supplement) 20 |
---|
40 | 40 | | |
---|
41 | 41 | | BY adding to 21 |
---|
42 | 42 | | Article – Insurance 22 |
---|
43 | 43 | | Section 15–857 23 |
---|
44 | 44 | | Annotated Code of Maryland 24 |
---|
45 | 45 | | (2017 Replacement Volume and 2021 Supplement) 25 |
---|
46 | 46 | | |
---|
47 | 47 | | SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 26 |
---|
48 | 48 | | That the Laws of Maryland read as follows: 27 2 SENATE BILL 787 |
---|
49 | 49 | | |
---|
50 | 50 | | |
---|
51 | 51 | | |
---|
52 | 52 | | Article – Health – General 1 |
---|
53 | 53 | | |
---|
54 | 54 | | 15–103. 2 |
---|
55 | 55 | | |
---|
56 | 56 | | (a) (1) The Secretary shall administer the Maryland Medical Assistance 3 |
---|
57 | 57 | | Program. 4 |
---|
58 | 58 | | |
---|
59 | 59 | | (b) (31) A MANAGED CARE ORGANIZ ATION MAY NOT APPLY A PRIOR 5 |
---|
60 | 60 | | AUTHORIZATION REQUIR EMENT FOR A PRESCRIP TION DRUG USED AS 6 |
---|
61 | 61 | | POSTEXPOSURE PROPHYL AXIS FOR THE PREVENT ION OF HIV IF THE 7 |
---|
62 | 62 | | PRESCRIPTION DRUG IS PRESCRIBED TO A VICT IM OF AN ALLEGED RAP E OR SEXUAL 8 |
---|
63 | 63 | | OFFENSE. 9 |
---|
64 | 64 | | |
---|
65 | 65 | | Article – Insurance 10 |
---|
66 | 66 | | |
---|
67 | 67 | | 15–857. 11 |
---|
68 | 68 | | |
---|
69 | 69 | | (A) (1) THIS SECTION APPLIES TO: 12 |
---|
70 | 70 | | |
---|
71 | 71 | | (I) INSURERS AND NONPROF IT HEALTH SERVICE PL ANS THAT 13 |
---|
72 | 72 | | PROVIDE COVERAGE FOR PRESCRIPTION DRUGS U NDER INDIVIDUAL, GROUP, OR 14 |
---|
73 | 73 | | BLANKET HEALTH INSUR ANCE POLICIES OR CON TRACTS THAT ARE ISSU ED OR 15 |
---|
74 | 74 | | DELIVERED IN THE STATE; AND 16 |
---|
75 | 75 | | |
---|
76 | 76 | | (II) HEALTH MAINTENANCE O RGANIZATIONS THAT PR OVIDE 17 |
---|
77 | 77 | | COVERAGE FOR PRESCRI PTION DRUGS UNDER IN DIVIDUAL OR GROUP CO NTRACTS 18 |
---|
78 | 78 | | THAT ARE ISSUED OR D ELIVERED IN THE STATE. 19 |
---|
79 | 79 | | |
---|
80 | 80 | | (2) AN INSURER, A NONPROFIT HEALTH S ERVICE PLAN, OR A HEALTH 20 |
---|
81 | 81 | | MAINTENANCE ORGANIZA TION THAT PROVIDES C OVERAGE FOR PRESCRIP TION 21 |
---|
82 | 82 | | DRUGS THROUGH A PHAR MACY BENEFITS MANAGE R IS SUBJECT TO THE 22 |
---|
83 | 83 | | REQUIREMENTS OF THIS SECTION. 23 |
---|
84 | 84 | | |
---|
85 | 85 | | (B) AN ENTITY S UBJECT TO THIS SECTI ON MAY NOT APPLY A P RIOR 24 |
---|
86 | 86 | | AUTHORIZATION REQUIR EMENT FOR A PRESCRIP TION DRUG USED AS 25 |
---|
87 | 87 | | POSTEXPOSURE PROPHYL AXIS FOR THE PREVENT ION OF HIV IF THE 26 |
---|
88 | 88 | | PRESCRIPTION DRUG IS PRESCRIBED TO A VICT IM OF AN ALLEGED RAP E OR SEXUAL 27 |
---|
89 | 89 | | OFFENSE. 28 |
---|
90 | 90 | | |
---|
91 | 91 | | SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall apply to all 29 |
---|
92 | 92 | | policies, contracts, and health benefit plans issued, delivered, or renewed in the State on or 30 |
---|
93 | 93 | | after January 1, 2023. 31 |
---|
94 | 94 | | |
---|
95 | 95 | | SECTION 3. AND BE IT FURTHER ENACTED, That this Act shall take effect 32 SENATE BILL 787 3 |
---|
96 | 96 | | |
---|
97 | 97 | | |
---|
98 | 98 | | January 1, 2023. 1 |
---|
99 | 99 | | |
---|